Related Experiment Video
Updated: Jan 6, 2026

05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.5K
Functional Variant Discovery Identifies a Novel Genetic Link between SPRY2, Wood Smoke, and Asthma
Arnav Gupta1,2, Amber Dahlin3, Alejandra Macario1
1Department of Medicine and.
American Journal of Respiratory Cell and Molecular Biology
|September 29, 2025
Summary
Wildfire smoke exposure increases asthma risk. Researchers found specific genetic variants, like rs3861144 affecting SPRY2, that influence how airway cells respond to wood smoke particles (WSP), offering new insights into asthma development.
Area of Science:
- Environmental Health
- Genetics
- Pulmonology
Background:
- Climate change and land use policies drive increased wildfire smoke.
- Wildfire smoke's impact on asthma is known, but genetic factors and molecular mechanisms remain unclear.
- This knowledge gap limits identifying high-risk individuals and developing targeted interventions.
Purpose of the Study:
- To identify genetic risk variants associated with asthma and wood smoke particle (WSP) exposure.
- To investigate the molecular mechanisms by which WSP influences asthma risk.
- To explore potential genetic biomarkers for asthma risk assessment.
Main Methods:
- Utilized the Genetic Epidemiology Research on Aging (GERA) cohort to identify genetic variants.
- Colocalized genetic risk variants with genomic responses to wood smoke particles (WSP).
- Tested allele-dependent transcriptional regulatory function of prioritized variants in airway epithelial cells.
Main Results:
- Identified 52 genetic risk variants associated with asthma and WSP exposure.
- The rs3861144 variant in SPRY2 demonstrated allele-dependent changes in response to WSP.
- These changes involved Interleukin-8 secretion, ERK activation, and cellular repair mechanisms.
Conclusions:
- Wildfire smoke particles (WSP) influence asthma risk through specific molecular pathways.
- The rs3861144 variant and SPRY2 gene are implicated in WSP-mediated asthma risk.
- Genetic candidates identified may serve as clinical tools for asthma risk stratification.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Pleiotropy
43.1K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.1K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K

